CIGB-500 in acute myocardial infarction (AMIGOS study)
Phase 1
Not yet recruiting
- Conditions
- Acute myocardial infarction
- Registration Number
- RPCEC00000177
- Lead Sponsor
- Center for Genetic Engineering and Biotechnology (CIGB), in Havana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
1) Compliance with the diagnostic criteria.
2) Patient presenting their first acute myocardial infarction (AMI).
3) Voluntary patient by providing their informed consent (oral).
Exclusion Criteria
1) Cardiogenic shock as a presentation.
2) significant coronary multivessel disease.
3) Patients previously revascularized.
4) diabetics or with a history of pituitary adenoma patients.
5) Patients with a diagnosis of malignancy.
6) Pregnancy or lactation at the time of inclusion in the study (reported by the patient).
7) Mental incapacity apparent consent to issue and act accordingly to the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method